Acute Promyelocytic Leukemia (APL), also known as AML-M3, is a subtype of Acute Myeloid Leukemia characterized by the presence of a specific genetic marker, the PML-RARA fusion gene. This condition can manifest with a variety of symptoms that necessitate prompt and accurate diagnosis. DNA Labs UAE offers a comprehensive PML-RARA AML – M3 APML Test to detect this genetic anomaly, aiding in the timely initiation of targeted therapies. The cost of this test is 1050 AED.
Symptoms of PML-RARA AML – M3 APML
Patients with Acute Promyelocytic Leukemia may exhibit a range of symptoms, which can vary significantly in severity. Early detection and diagnosis are crucial for effective treatment. Some of the common symptoms include:
Fatigue and weakness – Patients often experience a pronounced sense of tiredness and a lack of energy.
Fever – A persistent fever that does not have an obvious cause is a common symptom of APL.
Bleeding and bruising – APL can lead to easy bruising, bleeding gums, nosebleeds, and other symptoms of abnormal bleeding.
Weight loss – Unexplained weight loss can be a sign of APL, as with other types of leukemia.
Bone and joint pain – Pain in bones and joints can occur, which is not attributable to other causes.
Shortness of breath – Difficulty breathing or shortness of breath, especially during physical activities, may be observed.
Skin rashes – Some patients may develop petechiae, which are tiny red spots under the skin caused by bleeding.
Infections – An increased susceptibility to infections due to the compromised immune system.
PML-RARA AML – M3 APML Test at DNA Labs UAE
The PML-RARA AML – M3 APML Test offered by DNA Labs UAE is a sophisticated diagnostic tool designed to detect the presence of the PML-RARA fusion gene, which is indicative of Acute Promyelocytic Leukemia. The detection of this gene is pivotal for the accurate diagnosis and subsequent management of the disease. The test is priced at 1050 AED and is performed using state-of-the-art technology to ensure high sensitivity and specificity.
Early diagnosis through the PML-RARA AML – M3 APML Test facilitates the initiation of targeted therapy, significantly improving the prognosis for patients with APL. This test is an invaluable tool in the arsenal against Acute Promyelocytic Leukemia, providing both patients and healthcare providers with critical information that guides treatment decisions.
For more information about the PML-RARA AML – M3 APML Test and to schedule your test, please visit https://dnalabsuae.com/tests/pmlrara-aml-m3-apml-test/.
Conclusion
Acute Promyelocytic Leukemia is a serious condition that requires immediate attention and treatment. Recognizing the symptoms early on and undergoing the PML-RARA AML – M3 APML Test at DNA Labs UAE can be life-saving. With the test cost set at 1050 AED, it’s a small price to pay for a test that can provide critical insights into your health and guide the course of treatment. If you or someone you know is experiencing symptoms related to APL, consider reaching out to DNA Labs UAE for testing and consultation.
